Monday, 03 October 2022

 

 

LATEST NEWS Punjab Police Busts Inter-State Drug Cartel Winds Of Change Blowing In Gujarat As People Ready For Scripting A New Record: Bhagwant Mann Jai Ram Thakur dedicates and lays foundation stones of developmental projects worth Rs. 195.38 crore in Dharamshala Chetan Singh Jauramajra orders enquiry committee to submit report in Pathankot incident by Tuesday Rattan Group of Institutions organized Farewell Party for Professional Education students Sincere efforts of government brought prosperity to thousands of women in Himachal Kultar Singh Sandhwan made surprise visits to different markets to review procurement of paddy BJP National President Jagat Prakash Nadda Inaugurates BJP Office Building at Una Punjab Among Top Five States In The Country In Swachata Sarvekshan Award The Janata Darbar of Minister Anil Vij, which started on Saturday morning, ended at one o'clock in the midnight Bhagwant Mann slams Congress-BJP in Gujarat. 'BJP is putting government companies in sale, and Congress its MLAs ' Amit Kapoor attended ramleela organized by prabhu vandana natak Club Winds of change being witnessed in Gujarat : Bhagwant Mann After 'Delhi Crime 2', Rasika Dugal gets busy with Season 3 of 'Mirzapur' LeT terrorist killed in Shopian encounter Playing a sardarji hard for a person not used to a turban : Saanand Verma 'Drishyam 2' makers offer 50% discount on advance bookings made on Oct 2 Gaurav Khanna on his 'Anupamaa' character breaking stereotypes 'AAP to form govt in Gujarat', Kejriwal cites IB report Sterlite Technologies launches optical solution for 5G rollout 'Bigg Boss 16': Manya Singh couldn't get work for two years due to skin tone

 

This drug can fight more than 300 drug-resistant bacteria

Health, Study, New York, Research, Researchers, World News, Novel Drug Molecule

Web Admin

Web Admin

5 Dariya News

New York , 14 Aug 2022

A team of researchers have developed a novel drug molecule that can help ward off more than 300 drug-resistant bacteria.Reported in ACS Central Science journal, the drug compound called fabimycin, inhibited drug-resistant gram-negative bacteria in lab experiments, as well as in mice with pneumonia and urinary tract infections.

Gram-negative bacteria are a class of microbes that infect millions of people worldwide, and are especially difficult to treat because they have strong defense systems tough cell walls that keep most antibiotics out and pumps that efficiently remove those antibiotics that get inside.

The microbes can also mutate to evade multiple drugs. Furthermore, treatments that do work aren't very specific, eradicating many kinds of bacteria, including those that are beneficial.

Fabimycin, developed by a team from the University of Illinois in the US, showed potential to infiltrate the defences of gram-negative bacteria and treat infections, while leaving other helpful microbes intact.

The team led by Paul Hergenrother, from the varsity's Department of Chemistry, started with an antibiotic that was active against gram-positive bacteria and made a series of structural modifications that they believed would allow it to act against gram-negative strains.

Fabimycin proved potent against more than 300 drug-resistant clinical isolates, while remaining relatively inactive toward certain gram-positive pathogens and some typically harmless bacteria that live in or on the human body.

In addition, the new molecule reduced the amount of drug-resistant bacteria in mice with pneumonia or urinary tract infections to pre-infection levels or below, performing as well as or better than existing antibiotics at similar doses.

The researchers said the results show that fabimycin could one day be an effective treatment for stubborn infections.

 

Tags: Health , Study , New York , Research , Researchers , World News , Novel Drug Molecule

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD